The active substance is inosine pranobex (complex containing inosine and 2- hydroxypropyl dimethyl ammonium 4-acetamidobenzoate in molar ratio 1:3). 1 ml of syrup contains 100 mg of inosine pranobex.
5 ml of syrup contains 500 mg of inosine pranobex.
Viruzine Forte is an antiviral drug enhancing the body’s immunity (stimulates the immune system).
Viruzine Forte contains the active substance – inosine pranobex inhibiting the in vitro replication of herpes viruses which are pathogenic to humans.
Indications for use Viruzine Forte:
– as supportive therapy in immunocompromised persons in case of recurrent upper respiratory tract infections,
– in the treatment of lip and face herpes caused by the Herpes simplex virus. Viruzine Forte may be used only in patients with a history of diagnosed Herpes simplex virus infection.
To be completed
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
The active substance is inosine pranobex (complex containing inosine and 2- hydroxypropyl dimethyl ammonium 4-acetamidobenzoate in molar ratio 1:3). 1 ml of syrup contains 100 mg of inosine pranobex.
5 ml of syrup contains 500 mg of inosine pranobex.
Viruzine Forte is an antiviral drug enhancing the body’s immunity (stimulates the immune system).
Viruzine Forte contains the active substance – inosine pranobex inhibiting the in vitro replication of herpes viruses which are pathogenic to humans.
Indications for use Viruzine Forte:
– as supportive therapy in immunocompromised persons in case of recurrent upper respiratory tract infections,
– in the treatment of lip and face herpes caused by the Herpes simplex virus. Viruzine Forte may be used only in patients with a history of diagnosed Herpes simplex virus infection.
To be completed
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
